CollaGenex Pharmaceuticals Appoints George Lasezkay to its Board of Directors
CollaGenex Pharmaceuticals, Inc. announced the appointment of George Lasezkay, Pharm.D., J.D., to its Board of Directors. Dr. Lasezkay will also serve on the Board's audit committee.
Dr. Lasezkay has an extensive background in the pharmaceutical industry, including 13 years experience with Allergan, Inc., a specialty pharmaceutical company focusing on ophthalmology and dermatology, where he was Corporate Vice President, Corporate Development, and, before that, its Assistant General Counsel. He currently serves on the Board of Directors of Acuity Pharmaceuticals, Inc., Sucampo Pharmaceuticals, Inc., Novagali Pharma S.A. and Valentis Inc., and he is a former member of the Board of ISTA Pharmaceuticals, Inc. Dr. Lasezkay provides business development and strategic advisory services to emerging pharmaceutical and biotechnology companies as a Principal at Turning Point Consultants, LLC.
Most read news
Organizations
Other news from the department people
These products might interest you
Milli-Q® Services / MyMilli-Q™ by Merck Life Science
Services & Support for Water Purification Systems
Quality Care, Delivered. In Person & Online
Good Weighing Practice by Mettler-Toledo
Your Concrete Weighing Quality Assurance Plan
GWP Verification service
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.